NVCR — NovoCure Ltd
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1645113 ·
Jersey
Last close
$16.76
Market Cap
$1.95B
52W High
$21.45
52W Low
$13.43
ADV30
1,655,390
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 183,584,000 | 142,478,000 | -10,562,000 | -15,658,000 | 795,191,000 | 93,701,000 | 457,099,000 |
| Mar 2026 | 174,055,000 | 135,126,000 | -67,420,000 | -71,138,000 | 787,926,000 | 87,527,000 | 457,209,000 |
| Dec 2025 | 174,350,000 | 132,193,000 | -40,393,000 | -24,499,000 | 804,326,000 | 93,548,000 | 463,860,000 |
| Sep 2025 | 167,204,000 | 122,475,000 | -36,021,000 | -37,270,000 | 1,361,194,000 | 342,119,000 | 1,019,861,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-26,883,000
Investing CF
$451,495,000
Financing CF
$-456,756,000
CapEx
$-21,189,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.53
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,361,495,000
Inventory
$43,458,000
Receivables
$146,404,000
ST Investments
$344,477,000
EBIT TTM
$-148,768,000
Pretax Income TTM
$-175,213,000
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$699,193,024
EBITDA
$-136,392,992
Free Cash Flow
$22,763,750
Enterprise Value
$1,744,493,312
Total Cash
$440,559,008
Total Debt
$233,420,000
Shares Out
116,445,840
Trailing EPS
$-1.27
Book Value
$2.90
ROE
-43.2%
ROA
-9.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 655,353,000 | -153,800,000 | -136,227,000 | 804,326,000 | 463,860,000 | — | -49,031,000 |
| Dec 2024 | 605,220,000 | -170,496,000 | -168,627,000 | 1,240,784,000 | 880,605,000 | — | -26,369,000 |
| Dec 2023 | 509,338,000 | -232,870,000 | -207,043,000 | 1,146,129,000 | 783,633,000 | — | -73,336,000 |
| Dec 2022 | 537,840,000 | -89,523,000 | -92,534,000 | 1,191,648,000 | 750,478,000 | — | 30,788,000 |
TTM Snapshot
Revenues TTM
$547,020,000
NetIncome TTM
$-119,755,000
OpCashFlow TTM
$0
Assets (Latest)
$1,240,784,000
Forward EPS
$-0.82
Max Pain — expiry 2027-01-15
max pain strike: $13.00 · spot: $16.76 · call oi: 11,336 · put oi: 547
Expected Move to 2027-01-15:
±$5.37
(32.04%) —
implied range
$11.39 –
$22.13
· ATM straddle on $17.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LMAT | LEMAITRE VASCULAR INC | $1.83B | $79.96 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.82B | $37.19 | — |
| INSP | Inspire Medical Systems, Inc. | $1.78B | $61.47 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $2.15B | $72.06 | — |
| XRAY | DENTSPLY SIRONA Inc. | $2.17B | $10.89 | — |
News headlines (Yahoo Finance, 1h cache)
Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice
2026-08-20 16:00 · Yahoo
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet
2026-08-12 13:55 · Yahoo
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade
2026-07-27 13:55 · Yahoo
Unlocking NovoCure (NVCR) International Revenues: Trends, Surprises, and Prospects
2026-07-27 13:15 · Yahoo
NovoCure Limited Q2 2026 Earnings Call Summary
2026-07-24 12:30 · Yahoo
Why Did CSX, UNP, NVCR Stocks Surge To 52-Week Highs Today?
2026-07-24 03:45 · Yahoo
Novocure (NVCR) Hits New High on Optimistic Outlook, FDA Approval Hopes
2026-07-24 00:43 · Yahoo
Novocure Flashes A Bullish Signal As It Breaks Out. Have Shares 'Turned A Corner?'
2026-07-23 20:16 · Yahoo
NVCR Stock Surges 28% For Best Day In Over 1.5 Years — What’s Driving The Rally?
2026-07-23 20:09 · Yahoo
NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
2026-07-23 19:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.